Drug Type Synthetic peptide |
Synonyms UGP-302 |
Target |
Mechanism Amylin receptor agonists, CALCR agonists(Calcitonin receptor agonists) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC149H246N44O48S2 |
InChIKeyWGPKKADKWIWSCQ-XTWYBNIISA-N |
CAS Registry1432581-36-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Phase 2 | - | 08 Jun 2017 | |
Osteoarthritis | Discovery | US | 08 Jun 2017 | |
Osteoporosis | Discovery | US | 08 Jun 2017 | |
Nonalcoholic Steatohepatitis | Discovery | DK | 22 Oct 2015 | |
Obesity | Discovery | DK | 22 Jun 2013 |
Not Applicable | - | - | pmsoyefntf(qjeqoezejj) = dgwmacfahw ipqfnmtfmi (ffgkunaqye ) | Positive | 26 Sep 2013 | ||
sCT | pmsoyefntf(qjeqoezejj) = gnbgcizqtu ipqfnmtfmi (ffgkunaqye ) | ||||||
Not Applicable | - | oseamssphd(rdyilsdwmf) = hhaofrjbwc jmfwzqrfjy (beuyxhcwrd ) | - | 25 Sep 2013 | |||
oseamssphd(rdyilsdwmf) = tjlfvzcvio jmfwzqrfjy (beuyxhcwrd ) |